These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 10477389

  • 1. Induction and large-scale expansion of CD8+ tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells.
    Mackensen A, Wittnebel S, Veelken H, Noppen C, Spagnoli GC, Lindermann A.
    Eur Cytokine Netw; 1999 Sep; 10(3):329-36. PubMed ID: 10477389
    [Abstract] [Full Text] [Related]

  • 2. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG, Turcovski-Corrales SM, Taub DD.
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [Abstract] [Full Text] [Related]

  • 3. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M.
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [Abstract] [Full Text] [Related]

  • 4. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
    Li Y, McGowan P, Hellström I, Hellström KE, Chen L.
    J Immunol; 1994 Jul 01; 153(1):421-8. PubMed ID: 7515929
    [Abstract] [Full Text] [Related]

  • 5. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
    Oelke M, Moehrle U, Chen JL, Behringer D, Cerundolo V, Lindemann A, Mackensen A.
    Clin Cancer Res; 2000 May 01; 6(5):1997-2005. PubMed ID: 10815925
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
    Sulé-Suso J, Arienti F, Melani C, Colombo MP, Parmiani G.
    Eur J Immunol; 1995 Oct 01; 25(10):2737-42. PubMed ID: 7589065
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma.
    Gückel B, Meyer GC, Rudy W, Batrla R, Meuer SC, Bastert G, Wallwiener D, Moebius U.
    Cancer Gene Ther; 1999 Oct 01; 6(3):228-37. PubMed ID: 10359208
    [Abstract] [Full Text] [Related]

  • 11. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells.
    Yang S, Darrow TL, Seigler HF.
    Cancer Res; 1997 Apr 15; 57(8):1561-8. PubMed ID: 9108460
    [Abstract] [Full Text] [Related]

  • 12. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep 15; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 13. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
    Lu ZY, Condomines M, Tarte K, Nadal L, Delteil MC, Rossi JF, Ferrand C, Klein B.
    Exp Hematol; 2007 Mar 15; 35(3):443-53. PubMed ID: 17309825
    [Abstract] [Full Text] [Related]

  • 14. B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines.
    Iezzi G, Protti MP, Rugarli C, Bellone M.
    Cancer Res; 1996 Jan 01; 56(1):11-5. PubMed ID: 8548749
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis of a human melanoma cell line specifically induced by membrane-bound single-chain antibodies.
    de Inés C, Cochlovius B, Schmidt S, Kipriyanov S, Rode HJ, Little M.
    J Immunol; 1999 Oct 01; 163(7):3948-56. PubMed ID: 10490996
    [Abstract] [Full Text] [Related]

  • 16. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER.
    Cancer Res; 1999 Sep 15; 59(18):4642-50. PubMed ID: 10493519
    [Abstract] [Full Text] [Related]

  • 17. Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro.
    Kaufmann AM, Gissmann L, Street D, Schreckenberger C, Hunter M, Qiao L.
    Cell Immunol; 1996 May 01; 169(2):246-51. PubMed ID: 8620552
    [Abstract] [Full Text] [Related]

  • 18. Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells.
    Möller P, Möller H, Sun Y, Dorbic T, Henz BM, Wittig B, Schadendorf D.
    Cancer Gene Ther; 2000 Jul 01; 7(7):976-84. PubMed ID: 10917199
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines.
    Dessureault S, Gallinger S.
    J Surg Res; 1996 Jul 15; 64(1):42-8. PubMed ID: 8806472
    [Abstract] [Full Text] [Related]

  • 20. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R, Ronteltap C, Heuveling M, Debets R, Bolhuis R.
    Gene Ther; 2005 Jan 15; 12(2):140-6. PubMed ID: 15496961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.